Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zosano Pharma 34790 ARDENTECH COURT FREMONT CA 94555 USA

P: 510-745-1200

Description:

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.

Key Statistics

Overview:

Market Capitalization, $K 53,346
Shares Outstanding, K 17,723
Annual Sales, $ 0 K
Annual Net Income, $ -35,360 K
60-Month Beta 2.62
% of Insider Shareholders 0.71%
% of Institutional Shareholders 29.57%
Float, K 17,597
% Float 99.29%

Growth:

1-Year Return -35.15%
3-Year Return -91.64%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 82.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/14/19
Earnings Per Share ttm -2.28
EPS Growth vs. Prev Qtr 7.06%
EPS Growth vs. Prev Year 81.01%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-20 on 01/26/18

ZSAN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -157.42
Return-on-Assets (Before Tax) -94.17
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.38
Book Value/Share 1.06
Interest Coverage -92.05
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar